Lv2
120 积分 2021-11-25 加入
Discovery of an orally bioavailable, CNS active pan-mutant RET kinase heterobifunctional degrader
20天前
已完结
Discovery of XYD270 as a Potent, Selective, and Orally Efficacious BRD9 PROTAC for Cancer Therapy
23天前
已完结
What Happens in Successful Optimizations? A Survey of 2018–2024 Literature
28天前
已完结
Total Synthesis of Vestitol and Medicarpin
2个月前
已完结
Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton's Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies
2个月前
已完结
Highly potent and selective degrader targeting ERα to improve the treatment outcomes of breast cancer
2个月前
已完结
Liquid Chromatography Combined With Tandem Mass Spectrometry for the Pharmacokinetic and Metabolism Studies of PROTAC ARV-471 in Rats
2个月前
已完结
Unlocking the therapeutic potential of HDAC8-degrading PROTACs: progress, challenges, and future directions
2个月前
已完结
Design and Synthesis of Novel Dual Fluoro-Substituted 10,11-Methylenedioxy-pyrrolo[3,4-b]quinoline Alkaloid Analogs as Topo I/DDX5 Inhibitors for Colorectal Cancer
2个月前
已完结
Discovery of Pyrazoloquinazoline Analogues as Orally Bioavailable KRAS-G12D Inhibitors
3个月前
已完结
皖公网安备34019202002308
